Allegro Ophthalmics Company
Allegro Ophthalmics is dedicated to delivering and establishing Integrin Peptide TherapyTM.
Estimated Revenue:
Less than $1M
Funding Status:
Private Equity
Employee Number:
11-50
Industry:
PharmTech
Headquarters:
San Juan Capistrano, California, United States
Founded Date:
2011
Technology:
Cancer